Archived Insight | March 18, 2020

Segal in Forbes Article on Multiemployer Pension News

An article from Forbes analyzing the current roadblocks to multiemployer pension reforms leans heavily on insight from Segal on the crisis gripping these retirement plans.

Read the article.

Questions about this article?

Get in touch with our press team!

What this article covers

As noted in the article, multiemployer pension reform faces daunting challenges without a clear path to a resolution. These hurdles include finding a political compromise between those who want to help plans in crisis mainly through federal funds, as opposed to higher contributions from plan participants.

To learn more about this pressing issue, please read the article on Forbes.

Read the Article

Learn more from Segal

Lawyer And Business Person Discussing In The Office

Supreme Court Addresses Prohibited Transaction Lawsuits

As a result of the Supreme Court’s decision, it will be easier for participants to sue plans for everyday plan transactions with service providers.

Retirement, Compliance, Multiemployer Plans, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Asian Senior Woman Reading The Information Sheet Of Her Prescribed Medicine

Implications of Medicare Changes for Group Health Plans

Our insight discusses guidance for sponsors of group health plans as well as a chart showing the impact on Medicare Part D cost sharing in 2026.

Compliance, Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.